By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Diagnostics firm Iris International announced after the close of the market Tuesday that it has agreed to buy AlliedPath, an early-stage, high-complexity CLIA-certified laboratory, for up to $6 million.

Iris will pay $4.7 million in cash and an earn-out of up to $1.3 million subject to certain sales and earnings targets being reached during the next three years. The deal is expected to close by July 30.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.